Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-018-1379-z
Abstract: PurposeWhile statins are used as first-line treatments for high-risk patients with hypercholesterolemia, statin monotherapy is often insufficient to achieve target low-density lipoprotein cholesterol (LDL-C) levels. Second-line treatment options include up-titration of statin dose, switching to… read more here.
Keywords: risk; rosuvastatin; high risk; treated statin ... See more keywords
Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Atherosclerosis and Thrombosis"
DOI: 10.5551/jat.38794
Abstract: Aims: Cardiovascular risk persists despite intensive lipid lowering therapy using statins. Serum levels of lipoprotein (a) [Lp(a)] can be a residual cardiovascular risk for adverse events. Aim of the present study was to evaluate the… read more here.
Keywords: long term; treated statin; percutaneous coronary; coronary intervention ... See more keywords